Research Focus

Former Employee. Non-Divisional Cost; Visiting Investigator

Recent additions – View all

1. The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma

   Journal Article

   Toner, L. E.; Vrhovac, R.; Smith, E. A.; Gardner, J.; Heaney, M.; Gonen, M.; Teruya-Feldstein, J.; Sirotnak, F.; O'Connor, O. A.
   Clinical Cancer Research (2006)

   Fulltext@MSK | Save
2. Comparative animal models for the study of lymphohematopoietic tumors: Strengths and limitations of present approaches

   Journal Article

   O'Connor, O. A.; Toner, L. E.; Vrhovac, R.; Budak-Alpdogan, T.; Smith, E. A.; Bergman, P.
   Leukemia and Lymphoma (2005)

   Fulltext@MSK | Save
3. A novel antifolate 10-propargyl-10-deazaaminopterin (PDX) displays synergistic effects with gemcitabine in non-Hodgkin's lymphoma models in vitro and in vivo

   Meeting Abstract

   Vrhovac, R.; Toner, L. E.; Smith, E. A.; O'Connor, O. A.
   Journal of Clinical Oncology (2004)

   Fulltext@MSK | Save